Plasma lyso-Gb3: a biomarker for monitoring fabry patients during enzyme replacement therapy.

Sakuraba, Hitoshi

Plasma lyso-Gb3: a biomarker for monitoring fabry patients during enzyme replacement therapy. [electronic resource] - Clinical and experimental nephrology Aug 2018 - 843-849 p. digital

Publication Type: Journal Article

1437-7799

10.1007/s10157-017-1525-3 doi


Biomarkers--blood
Enzyme Replacement Therapy
Fabry Disease--drug therapy
Female
Glycolipids--blood
Humans
Male
Sphingolipids--blood
alpha-Galactosidase